Genetic Testing in Nephrotic Syndrome--challenges and Opportunities

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2013 Jan 17

PMID 23321566

Citations 30

Authors

Rasheed A Gbadegesin

Michelle P Winn

William E Smoyer

Affiliations

Soon will be listed here.

Abstract

Monogenic nephrotic syndrome (nephrotic syndrome caused by a single gene defect) is responsible for only a small percentage of cases of nephrotic syndrome, but information from studies of the unique cohort of patients with this form of the disease has dramatically improved our understanding of the disease pathogenesis. The use of genetic testing in the management of children and adults with nephrotic syndrome poses unique challenges for clinicians in terms of who to test and how to use the information obtained from testing in the clinical setting. In our view, not enough data exist at present to justify the routine genetic testing of all patients with nephrotic syndrome. Testing is warranted, however, in patients with congenital nephrotic syndrome (onset at 0-3 months), infantile nephrotic syndrome (onset at 3-12 months), a family history of nephrotic syndrome, and those in whom nephrotic syndrome is associated with other congenital malformations. The family and/or the patient should be given complete and unbiased information on the potential benefits and risks associated with therapy, including the reported outcomes of treatment in patients with similar mutations. Based on the data available in the literature so far, intensive immunosuppressive treatment is probably not indicated in monogenic nephrotic syndrome if complete or partial remission has not been achieved within 6 weeks of starting treatment. We advocate that family members of individuals with genetic forms of nephrotic syndrome undergo routine genetic testing prior to living-related kidney transplantation. Prospective, multicentre studies are needed to more completely determine the burden of disease caused by monogenic nephrotic syndrome, and randomized controlled trials are needed to clarify the presence or absence of clinical responses of monogenic nephrotic syndrome to available therapies.

Citing Articles

Genetic and clinical spectrum of steroid-resistant nephrotic syndrome with nuclear pore gene mutation.

Yang H, Zhu G, Shao W, Liao P, Yan Y, Wang C Pediatr Nephrol. 2025; .

PMID: 39814977 DOI: 10.1007/s00467-024-06618-9.

Percutaneous Ultrasound-Guided Renal Biopsy in Greek Children: 15 Years of Experience at a Single Center.

Dotis J, Kondou A, Karava V, Siolos P, Georgopoulou V, Liapis G Pediatr Rep. 2024; 16(4):974-982.

PMID: 39585037 PMC: 11587433. DOI: 10.3390/pediatric16040083.

Comparison of different genetic testing modalities applied in paediatric patients with steroid-resistant nephrotic syndrome.

Cheng X, Chen J, Yang X, Chan H, Yang X, Jiao J Ital J Pediatr. 2024; 50(1):85.

PMID: 38654395 PMC: 11040871. DOI: 10.1186/s13052-024-01655-4.

New insights from the genetic work-up in early onset nephrotic syndrome: report from a registry in western India.

Sharma J, Saha A, Ohri A, More V, Shah F, Dave J Pediatr Nephrol. 2024; 39(7):2099-2104.

PMID: 38294522 DOI: 10.1007/s00467-024-06295-8.

Biochemical markers of nephrotic syndrome: An observational, cross-sectional study.

Ofori E, Clinton E, Acheampong O, Anane H, Amponsah S, Su J Heliyon. 2023; 9(4):e15198.

PMID: 37089385 PMC: 10113854. DOI: 10.1016/j.heliyon.2023.e15198.

References

Dreyer S, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W . Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet. 1998; 19(1):47-50. DOI: 10.1038/ng0598-47. View

. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981; 98(4):561-4. DOI: 10.1016/s0022-3476(81)80760-3. View

Weber S, Gribouval O, Esquivel E, Moriniere V, Tete M, Legendre C . NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 2004; 66(2):571-9. DOI: 10.1111/j.1523-1755.2004.00776.x. View

Winn M, Alkhunaizi A, Bennett W, Garber R, Howell D, Butterly D . Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis. 1999; 33(5):970-4. DOI: 10.1016/s0272-6386(99)70435-x. View

Sanjad S, Al-Abbad A . Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy. J Pediatr. 1997; 130(3):470-4. DOI: 10.1016/s0022-3476(97)70213-0. View

Ruf R, Lichtenberger A, Karle S, Haas J, Anacleto F, Schultheiss M . Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004; 15(3):722-32. DOI: 10.1097/01.asn.0000113552.59155.72. View

Hinkes B, Wiggins R, Gbadegesin R, Vlangos C, Seelow D, Nurnberg G . Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006; 38(12):1397-405. DOI: 10.1038/ng1918. View

Shih N, Li J, Karpitskii V, Nguyen A, Dustin M, Kanagawa O . Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science. 1999; 286(5438):312-5. DOI: 10.1126/science.286.5438.312. View

Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

10.

Gbadegesin R, Lavin P, Hall G, Bartkowiak B, Homstad A, Jiang R . Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int. 2011; 81(1):94-9. PMC: 3694501. DOI: 10.1038/ki.2011.297. View

11.

Buscher A, Konrad M, Nagel M, Witzke O, Kribben A, Hoyer P . Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin Nephrol. 2012; 78(1):47-53. DOI: 10.5414/cn107320. View

12.

Santin S, Bullich G, Tazon-Vega B, Garcia-Maset R, Gimenez I, Silva I . Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011; 6(5):1139-48. PMC: 3087781. DOI: 10.2215/CJN.05260610. View

13.

Conrad D, Keebler J, DePristo M, Lindsay S, Zhang Y, Casals F . Variation in genome-wide mutation rates within and between human families. Nat Genet. 2011; 43(7):712-4. PMC: 3322360. DOI: 10.1038/ng.862. View

14.

Brown E, Schlondorff J, Becker D, Tsukaguchi H, Tonna S, Uscinski A . Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2009; 42(1):72-6. PMC: 2980844. DOI: 10.1038/ng.505. View

15.

Buscher A, Kranz B, Buscher R, Hildebrandt F, Dworniczak B, Pennekamp P . Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010; 5(11):2075-84. PMC: 3001773. DOI: 10.2215/CJN.01190210. View

16.

Valdivielso P, Moliz M, Valera A, Corrales M, Sanchez-Chaparro M, Gonzalez-Santos P . Atorvastatin in dyslipidaemia of the nephrotic syndrome. Nephrology (Carlton). 2004; 8(2):61-4. DOI: 10.1046/j.1440-1797.2003.00143.x. View

17.

Winn M, Conlon P, Lynn K, Farrington M, Creazzo T, Hawkins A . A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005; 308(5729):1801-4. DOI: 10.1126/science.1106215. View

18.

Kaplan J, Kim S, North K, Rennke H, Correia L, Tong H . Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000; 24(3):251-6. DOI: 10.1038/73456. View

19.

Kopp J, Smith M, Nelson G, Johnson R, Freedman B, Bowden D . MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008; 40(10):1175-84. PMC: 2827354. DOI: 10.1038/ng.226. View

20.

Ransom R, Lam N, Hallett M, Atkinson S, Smoyer W . Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int. 2005; 68(6):2473-83. DOI: 10.1111/j.1523-1755.2005.00723.x. View